DUSTIN NICKERSON: Open Payments
NPI 1760988224 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,827 in 77 payments from 20 companies in 2025. Trend: 2023 $3,610 · 2024 $28,272 · 2025 $2,827
Food & beverage: $1,502Speaker / faculty: $1,250Education: $57Travel & lodging: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $1,554 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $307 |
| Amgen Inc. | 14 | $213 |
| Calliditas Therapeutics US Inc. | 5 | $128 |
| Vantive US Healthcare LLC | 1 | $105 |
| Lilly USA, LLC | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| OPKO Pharmaceuticals, LLC | 3 | $57 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $45 |
| Alexion Pharmaceuticals, Inc. | 2 | $41 |
Products named: LOKELMA, FARXIGA, Kerendia, KRYSTEXXA, JARDIANCE, TARPEYO, RAYALDEE, TAVNEOS.
Industry payments across AZ — which companies pay providers there.
